Having trouble accessing articles? Reset your cache.

Ivermectin: Phase II data

A double-blind, dose-ranging, U.S. Phase II trial in 74 evaluable patients showed that all 3

Read the full 152 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE